Zhejiang Three Stars New Materials (603578)
Search documents
今日135只个股突破年线
Zheng Quan Shi Bao Wang· 2026-01-23 07:49
Group 1 - The Shanghai Composite Index closed at 4136.16 points, above the annual line, with a change of 0.33% [1] - The total trading volume of A-shares reached 31,181.08 billion yuan [1] - A total of 135 A-shares have surpassed the annual line, with notable stocks showing significant deviation rates [1] Group 2 - The stocks with the highest deviation rates include Optech (24.77%), JinkoSolar (19.13%), and Huamin Co. (15.02%) [1] - Other stocks that have just crossed the annual line include Zhengfan Technology, Zhuochuang Information, and Zhongke Information, with smaller deviation rates [1] - The trading performance of the top stocks includes Optech with a daily increase of 29.98% and a turnover rate of 18.93% [1]
1月16日晚间重要公告一览





Xi Niu Cai Jing· 2026-01-16 10:19
Group 1 - Xianghe Industrial signed a contract worth 43.1041 million yuan with China Railway 15th Bureau, accounting for approximately 6.5% of the company's projected revenue for 2024 [1] - Dayu Water-saving's subsidiary won a bid for a project valued at 133 million yuan, with a construction period of 545 days [2] - China National Materials International's subsidiary signed a contract worth 299 million Canadian dollars for engineering design and procurement services [3] Group 2 - Baoland expects a net loss of approximately 75 million yuan for 2025, compared to a loss of 58.7224 million yuan in the previous year [4] - Changhong High-tech received an administrative regulatory decision due to inadequate internal controls and improper revenue recognition [5] - Debon Stock will be suspended from trading on January 21, 2026, pending a decision on its delisting [6] Group 3 - Haitai Technology anticipates a net profit increase of 226.86% to 323.97% for 2025, with an expected profit of 51.5 million to 66.8 million yuan [7] - Fushun Special Steel expects a net loss of 770 million to 870 million yuan for 2025, compared to a profit of 112 million yuan in the previous year [8] - Rejing Bio forecasts a net loss of 210 million to 230 million yuan for 2025, compared to a loss of 191 million yuan in the previous year [10] Group 4 - Sanyou Chemical expects a net profit of approximately 91 million yuan for 2025, a decrease of about 82% compared to the previous year [11] - Lianhuan Pharmaceutical received approval for clinical trials of a new drug for benign prostatic hyperplasia [12] - Samsung New Materials anticipates a net loss for 2025, indicating a decline in operational performance [13] Group 5 - Jinggong Technology expects a net profit increase of 36.1% to 70.13% for 2025, with an estimated profit of 200 million to 250 million yuan [14] - Zhongsheng Pharmaceutical's subsidiary signed a licensing agreement for the production and commercialization of RAY1225 injection, with total payments expected to reach 1 billion yuan [15] - Hengshuai shares saw a reduction of 600,000 convertible bonds held by its controlling shareholder [16] Group 6 - Buchang Pharmaceutical plans to repurchase shares worth 60 million to 120 million yuan for employee stock ownership plans [17] - Baike Bio expects a net loss of 220 million to 280 million yuan for 2025, marking a shift from profit to loss [18] - Weishi Electronics anticipates a net profit decrease of 53.27% to 61.61% for 2025, with expected profits of 21.49 million to 26.16 million yuan [19] Group 7 - China Automotive Research expects a net profit increase of 17.85% for 2025, with a projected profit of 1.06 billion yuan [20] - Hualan Biological's controlling shareholder raised the upper limit of its shareholding plan to 86.66 yuan per share [22] - Nasda anticipates a net loss for 2025, indicating a decline in financial performance [23] Group 8 - Haizheng Pharmaceutical received a warning letter from the Zhejiang Securities Regulatory Commission for financial data inaccuracies [24] - Mengguli received an administrative regulatory decision for accounting errors in its financial reports [25] - Zhongguancun's subsidiary received acceptance for a drug application for a heart-related treatment [26] Group 9 - Hosheng Silicon Industry was ordered to correct information disclosure violations by the Zhejiang Securities Regulatory Commission [27] - Meiteng Technology expects a net profit decrease of 22.4551 million to 28.5285 million yuan for 2025, a reduction of 55.21% to 70.14% [28] - Sanwei Co. received a warning letter for financial irregularities related to related party transactions [29] Group 10 - Ganyue Expressway expects a net profit increase of 3.18% for 2025, with a projected profit of 1.32 billion yuan [30] - Xinhang New Materials plans to acquire 51% of Hairete for 12.8826 million yuan [31] - China Software anticipates a net loss of 41 million to 49 million yuan for 2025, an improvement from the previous year's loss [32] Group 11 - Rongsheng Development expects a net loss for 2025, with losses not exceeding the previous year's audited net assets [33] - Northern Rare Earth anticipates a net profit increase of 117% to 135% for 2025, with expected profits of 2.176 billion to 2.356 billion yuan [34] - Energy-saving Wind Power received renewable energy subsidies totaling 1.507 billion yuan, a 122.74% increase from the previous year [35] Group 12 - Dongzhu Ecology expects a net loss of 935 million to 1.135 billion yuan for 2025, compared to a loss of 630 million yuan in the previous year [36] - Jingneng Real Estate anticipates a net loss of 986 million to 1.315 billion yuan for 2025, compared to a loss of 109 million yuan in the previous year [37] - Hailu Heavy Industry signed new orders worth 1.941 billion yuan for 2025, with total orders on hand amounting to 3.597 billion yuan [38] Group 13 - Dalian Thermal Power expects a net loss of 92 million to 112 million yuan for 2025, compared to a loss of 146 million yuan in the previous year [39] - Jiangsu Sop expects a net profit decrease of 52.99% to 62.4% for 2025, with profits projected between 8 million to 10 million yuan [40] - Lian Technology plans to initiate preparations for issuing H-shares and listing on the Hong Kong Stock Exchange [42] Group 14 - Zhenyang Development expects a net profit decrease of 58.13% to 64.94% for 2025, with profits projected between 67 million to 80 million yuan [43] - Sheneng Co. reported a 1.7% decrease in power generation for 2025, with total generation of 57.654 billion kWh [44] - XGIMI Technology's subsidiary received a development notification from a well-known domestic automotive manufacturer [45] Group 15 - Wanhua Chemical's MDI Phase II facility resumed production after maintenance [46] - Daqing Energy expects a net loss of 1 billion to 1.3 billion yuan for 2025, with a reduction in losses compared to the previous year [47]
三星新材(603578) - 2025 Q4 - 年度业绩预告
2026-01-16 10:05
2025 年年度业绩预亏的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 经浙江三星新材股份有限公司(以下简称"公司")财务部门初步测算,预计 公司 2025 年度归属于上市公司股东的净利润为负值,公司 2025 年年度经营业绩 将出现亏损。 公司将严格遵守《上海证券交易所股票上市规则》等相关规定,加快推进财 务核算工作,在规定期限内尽快披露公司 2025 年年度业绩预告。具体准确的财 务数据以公司正式披露的经审计后的 2025 年年度报告为准。 敬请广大投资者理性投资,注意投资风险。 证券代码:603578 证券简称:三星新材 公告编号:2026-002 浙江三星新材股份有限公司 浙江三星新材股份有限公司董事会 2026 年 1 月 17 日 特此公告。 ...
三星新材:预计2025年度净利润为负
Xin Lang Cai Jing· 2026-01-16 08:33
三星新材公告,经公司财务部门初步测算,预计2025年度归属于上市公司股东的净利润为负值,公司 2025年年度经营业绩将出现亏损。公司将严格遵守相关规定,加快推进财务核算工作,在规定期限内尽 快披露公司2025年年度业绩预告。具体准确的财务数据以公司正式披露的经审计后的2025年年度报告为 准。 ...
三星新材:关于公司通过高新技术企业重新认定的公告
Zheng Quan Ri Bao· 2026-01-09 12:12
证券日报网讯 1月9日,三星新材发布公告称,根据全国高新技术企业认定管理工作领导小组办公室于 2026 年 1 月 9 日发布的《对浙江省认定机构 2025 年认定报备高新技术企业进行备案的公告》,浙江三 星新材股份有限公司(以下简称"公司")被列入《浙江省认定机构 2025 年认定报备的高新技术企业备 案名单》,公司通过了高新技术企业的认定,证书编号为 GR202533004890,发证日期为 2025 年 12 月 19 日,有效期三年。本次认定系公司原高新技术企业证书有效期满后进行的重新认定。 (文章来源:证券日报) ...
三星新材(603578.SH):公司通过高新技术企业重新认定
Ge Long Hui A P P· 2026-01-09 08:32
本次认定系公司原高新技术企业证书有效期满后进行的重新认定。根据《中华人民共和国企业所得税 法》及国家对高新技术企业的相关税收政策规定,公司自通过本次高新技术企业重新认定起连续三年 (2025年、2026年、2027年)可继续享受高新技术企业税收优惠,即按 15%的税率缴纳企业所得税。 格隆汇1月9日丨三星新材(603578.SH)公布,根据全国高新技术企业认定管理工作领导小组办公室于 2026年1月9日发布的《对浙江省认定机构2025年认定报备高新技术企业进行备案的公告》,公司被列入 《浙江省认定机构2025年认定报备的高新技术企业备案名单》,公司通过了高新技术企业的认定,证书 编号为 GR202533004890,发证日期为2025年12月19日,有效期三年。 ...
三星新材(603578) - 关于公司通过高新技术企业重新认定的公告
2026-01-09 08:15
浙江三星新材股份有限公司 证券代码:603578 证券简称:三星新材 公告编号:2026-001 关于公司通过高新技术企业重新认定的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 2026 年 1 月 10 日 本次认定系公司原高新技术企业证书有效期满后进行的重新认定。根据《中 华人民共和国企业所得税法》及国家对高新技术企业的相关税收政策规定,公司 自通过本次高新技术企业重新认定起连续三年(2025 年、2026 年、2027 年)可 继续享受高新技术企业税收优惠,即按 15%的税率缴纳企业所得税。 特此公告。 浙江三星新材股份有限公司董事会 根据全国高新技术企业认定管理工作领导小组办公室于 2026 年 1 月 9 日发 布的《对浙江省认定机构 2025 年认定报备高新技术企业进行备案的公告》,浙 江三星新材股份有限公司(以下简称"公司")被列入《浙江省认定机构 2025 年 认定报备的高新技术企业备案名单》,公司通过了高新技术企业的认定,证书编 号为 GR202533004890,发证日期为 2025 年 12 月 ...
三星新材(603578) - 关于高级管理人员减持股份计划时间届满暨减持结果的公告
2025-12-29 09:16
证券代码:603578 证券简称:三星新材 公告编号:2025-066 浙江三星新材股份有限公司 关于高级管理人员减持股份计划时间届满暨减持结果的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导 性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 高级管理人员持股的基本情况 截至本公告披露日,浙江三星新材股份有限公司(以下简称"公司")副总 经理张金珠女士、副总经理王雪永先生分别持有公司无限售条件流通股 21.2 万 股、27.3 万股,分别约占公司股份总数的比例均为 0.12%、0.15%。 减持计划的实施结果情况 公司于 2025 年 9 月 6 日披露了《高级管理人员集中竞价减持股份计划公告》 (公告编号:2025-049),公司副总经理张金珠女士、副总经理王雪永先生分别 计划自 2025 年 9 月 29 日至 2025 年 12 月 28 日期间,均通过集中竞价方式减持 各自持有的公司无限售条件流通均为合计不超过 68,000 股,占公司总股本的比 例均为不超过 0.04%。 近日,公司收到副总经理张金珠女士、副总经理王雪永先生各自发来的 ...
三星新材:副总经理张金珠减持6万股,减持计划时间已届满
Mei Ri Jing Ji Xin Wen· 2025-12-29 09:15
2024年1至12月份,三星新材的营业收入构成为:非金属矿物制品业占比98.53%,其他业务占比 1.47%。 每经AI快讯,三星新材(SH 603578,收盘价:12.07元)12月29日晚间发布公告称,近日,公司收到副 总经理张金珠女士、副总经理王雪永先生各自发来的《关于减持股份计划时间届满暨减持结果的告知 函》。截至2025年12月28日,张金珠女士、王雪永先生的减持股份计划时间均已届满,张金珠女士按照 减持股份计划减持了6万股,王雪永先生未减持股份。 每经头条(nbdtoutiao)——直击茅台经销商大会:2000多人周末齐聚!重大变革公布:涉及茅台酒价 格、分销等,董事长陈华:经销商不能再"躺着赚钱" 截至2025年12月28日,张金珠女士、王雪永先生的减持股份计划时间均已届满,张金珠女士按照减持股 份计划减持了6万股,王雪永先生未减持股份。 (记者 王晓波) 截至发稿,三星新材市值为22亿元。 ...
三星新材(603578.SH):副总经理张金珠已减持6万股股份
Ge Long Hui A P P· 2025-12-29 09:07
格隆汇12月29日丨三星新材(603578.SH)公布,近日,公司收到副总经理张金珠女士、副总经理王雪永 先生各自发来的《关于减持股份计划时间届满暨减持结果的告知函》。截至2025年12月28日,张金珠女 士、王雪永先生的减持股份计划时间均已届满,张金珠女士按照减持股份计划减持了6万股,王雪永先 生未减持股份。 ...